JP Morgan Healthcare Conference – Day 3 Highlights (Obesity & Metabolic Therapies)

JP Morgan Healthcare Conference – Day 3 Highlights (Obesity & Metabolic Therapies)1. Shift From “Weight Loss” to Chronic Metabolic DiseaseDay 3 discussions made it clear that industry messaging is moving away from cosmetic weight loss and toward lifelong metabolic disease management.Key framing heard repeatedly:Obesity as a multisystem, chronic diseaseGLP-1–based therapies positioned alongside statins or antihypertensives, […]

Itching at the GLP-1 site of injection

Some people will get itching at the site of injection of the GLP-1 drugs. This is not common but is irritating. There are some things you can do to lessen the severity of the reaction.

EASO Framework for Pharmacological Obesity Treatment – Sick Fat vs. Fat Mass

A framework published by the European Association for the Study of Obesity (EASO) that addresses the pharmacological treatment of obesity and its complications. This framework proposes a new treatment algorithm that goes beyond solely focusing on weight loss, instead adopting a holistic approach by aiming to prevent or improve associated complications, such as heart failure and type 2 diabetes. The […]